Company Overview

SOL Global Investments Corp. is a publicly traded Canadian investment company focused on providing capital, strategic support, and operational expertise to companies primarily in the cannabis, life sciences, and consumer packaged goods sectors. The company operates as an investment holding and merchant banking platform, seeking minority and controlling interests in businesses where it believes active involvement can enhance value creation. Its revenue and asset value are primarily driven by investment performance, asset appreciation, and, to a lesser extent, management and advisory activities associated with its portfolio companies.

Originally incorporated as Scythian Biosciences Corp. in 2014, the company initially pursued opportunities in pharmaceutical cannabinoids and plant-based therapeutics. Following strategic and leadership changes, it rebranded to SOL Global Investments Corp. in 2019 to reflect a broader investment mandate beyond pure biotechnology. Since then, SOL has evolved into a diversified investment vehicle with a strong emphasis on cannabis-related assets, particularly in the United States, positioning itself as an early-stage and growth-focused investor in regulated markets.

Business Operations

SOL Global Investments Corp. operates through a centralized investment management structure rather than traditional operating segments. Its core business consists of identifying, acquiring, and managing equity interests in public and private companies, with a historical concentration in U.S. multi-state cannabis operators, cannabis retail platforms, and ancillary service providers. The company generates value through capital appreciation, strategic exits, and, in some cases, board representation or advisory influence within its investee companies.

The company’s assets include equity stakes, warrants, and convertible instruments, and it may also provide bridge financing or structured investments. SOL does not operate cultivation, manufacturing, or retail facilities directly; instead, it relies on its portfolio companies’ operations. Domestic operations are centered in Canada, while the majority of underlying investments are exposed to the United States cannabis market. Disclosures indicate involvement with multiple subsidiaries and investment vehicles used to hold and manage portfolio interests; however, the exact operational contribution of each subsidiary varies, and some details are not consistently disclosed across reporting periods. Where portfolio composition has changed rapidly, data is inconclusive based on available public sources.

Strategic Position & Investments

Strategically, SOL Global Investments Corp. positions itself as an active investor targeting dislocated or emerging segments within regulated industries, particularly U.S. cannabis, where federal restrictions historically limited institutional capital. Growth initiatives have emphasized acquiring significant stakes in operators with scalable retail footprints, branded consumer products, or vertically integrated models. The company has publicly stated its intent to benefit from potential regulatory liberalization in the United States, though outcomes remain uncertain and are subject to external policy developments.

Historically notable investments have included significant positions in Bluma Wellness Inc. (which was later acquired by Cresco Labs Inc.) and interests in other U.S.-focused cannabis companies. The company has also evaluated opportunities in plant-based wellness and consumer sectors adjacent to cannabis. Investment turnover has been relatively high, with assets bought, sold, or restructured as market conditions evolved. While management has highlighted diversification and disciplined capital allocation as priorities, the exact long-term sector balance remains fluid based on market conditions and capital availability.

Geographic Footprint

SOL Global Investments Corp. is headquartered in Toronto, Ontario, Canada, and is listed on Canadian public markets. Its corporate operations, governance, and financial reporting are primarily based in Canada, while its investment exposure is largely international through portfolio companies rather than direct operations.

The company’s most significant geographic exposure has been to the United States, reflecting its strategic focus on U.S. cannabis and consumer markets. Portfolio companies have operated across multiple U.S. states, giving SOL indirect presence in several regional markets. Outside of North America, there is limited evidence of sustained operational or investment exposure, and any non‑U.S., non‑Canadian activities appear immaterial based on publicly available disclosures.

Leadership & Governance

SOL Global Investments Corp.’s leadership has played a central role in shaping its transition from a biotechnology-focused entity to an investment platform. Governance follows a typical Canadian public company structure, with a board of directors overseeing management and investment strategy. The leadership philosophy emphasizes active ownership, opportunistic investing, and hands-on involvement where influence can drive operational or strategic improvements at the portfolio level.

Key executives and directors include:

• Andy DeFrancesco – Chief Executive Officer
• Steve Stabler – President
• Luke Norman – Chief Financial Officer
• Peter Rudnick – Director
• Andrew Ridenour – Director

Management and board composition have changed over time, reflecting shifts in strategy and market conditions. While executive leadership has articulated a long-term vision centered on value realization from undercapitalized growth sectors, execution and outcomes remain dependent on external market dynamics and regulatory developments.